Save time and get answers to complex questions with AI chat
Symbravo ingredients mechanism of action?When will latisse patent expire?How much is mebendazole?When will tenofovir alafenide come off patent in canada?Dabrafenib mesylate when the patent is expiring in india?
See the DrugPatentWatch profile for zepbound
Zepbound (tirzepatide) is an injection, not a pill. It's administered as a weekly subcutaneous injection using a single-dose pen or vial.[1]
Patients inject it under the skin in the abdomen, thigh, or upper arm once weekly. The starting dose is 2.5 mg, increasing gradually to a maximum of 15 mg based on tolerance and response.[1]
No oral pill form exists. Zepbound is only available as an injectable. Eli Lilly, its manufacturer, has no approved oral tirzepatide product.[1]
Unlike injectables like Zepbound or Wegovy, oral options like phentermine or orlistat are daily pills but generally less effective for significant weight loss. Zepbound's trials showed 15-21% average weight reduction over 72 weeks, outperforming most orals.[2][1]
Eli Lilly developed and markets Zepbound, FDA-approved in November 2023 for chronic weight management in adults with obesity or overweight plus related conditions.[1] [1]: FDA Label for Zepbound [2]: NEJM Tirzepatide Trial
Other Questions About Zepbound :